TCM
PFE icon

Tufton Capital Management’s Pfizer PFE Stock Holding History

Tufton Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,323
Closed -$225K – 120
2025
Q2 		$225K Hold
9,323
– – 0.04% 112
2025
Q1 		$236K Buy
9,323
+250
+3% +$6.54K 0.05% 114
2024
Q4 		$241K Sell
9,073
-599
-6% -$16.2K 0.05% 114
2024
Q3 		$280K Buy
9,672
+619
+7% +$18.1K 0.05% 110
2024
Q2 		$253K Hold
9,053
– – 0.05% 115
2024
Q1 		$251K Sell
9,053
-700
-7% -$19.4K 0.05% 112
2023
Q4 		$281K Sell
9,753
-375
-4% -$11.3K 0.06% 109
2023
Q3 		$336K Hold
10,128
– – 0.07% 98
2023
Q2 		$371K Sell
10,128
-225
-2% -$8.76K 0.08% 97
2023
Q1 		$422K Hold
10,353
– – 0.09% 90
2022
Q4 		$530K Buy
10,353
+1,970
+23% +$94.4K 0.12% 87
2022
Q3 		$366K Hold
8,383
– – 0.09% 90
2022
Q2 		$439K Hold
8,383
– – 0.08% 90
2022
Q1 		$433K Buy
8,383
+1,287
+18% +$66.8K 0.07% 93
2021
Q4 		$419K Buy
7,096
+1,205
+20% +$59.7K 0.06% 104
2021
Q3 		$253K Sell
5,891
-211
-3% -$9.35K 0.04% 115
2021
Q2 		$238K Buy
6,102
+499
+9% +$19.4K 0.04% 118
2021
Q1 		$202K Hold
5,603
– – 0.03% 126
2020
Q4 		$206K Sell
5,603
-303
-5% -$11.1K 0.04% 120
2020
Q3 		$205K Buy
+5,906
New +$207K 0.04% 115
2020
Q1 		– Sell
-6,043
Closed -$224K – 116
2019
Q4 		$224K Hold
6,043
– – 0.04% 114
2019
Q3 		$205K Sell
6,043
-595
-9% -$21.6K 0.04% 117
2019
Q2 		$272K Buy
6,638
+32
+0.5% +$1.27K 0.06% 112
2019
Q1 		$266K Buy
6,606
+1,076
+19% +$43.1K 0.06% 109
2018
Q4 		$229K Sell
5,530
-53
-0.9% -$2.2K 0.06% 110
2018
Q3 		$233K Sell
5,583
-992
-15% -$38.2K 0.05% 115
2018
Q2 		$226K Sell
6,575
-105
-2% -$3.59K 0.05% 113
2018
Q1 		$224K Sell
6,680
-192
-3% -$6.6K 0.04% 120
2017
Q4 		$236K Buy
6,872
+79
+1% +$2.69K 0.05% 123
2017
Q3 		$230K Buy
+6,793
New +$218K 0.05% 121
2016
Q1 		– Sell
-7,473
Closed -$229K – 101
2015
Q4 		$229K Sell
7,473
-1,576
-17% -$49.6K 0.06% 91
2015
Q3 		$270K Buy
9,049
+400
+5% +$12.8K 0.06% 90
2015
Q2 		$275K Sell
8,649
-7,805
-47% -$254K 0.06% 92
2015
Q1 		$543K Sell
16,454
-505
-3% -$16.1K 0.1% 91
2014
Q4 		$501K Sell
16,959
-2,446
-13% -$70.1K 0.09% 94
2014
Q3 		$544K Buy
19,405
+316
+2% +$8.87K 0.1% 96
2014
Q2 		$538K Sell
19,089
-2,061
-10% -$58.8K 0.11% 98
2014
Q1 		$645K Buy
21,150
+1,366
+7% +$40.7K 0.13% 94
2013
Q4 		$575K Sell
19,784
-2,119
-10% -$61.7K 0.12% 96
2013
Q3 		$597K Buy
21,903
+5,033
+30% +$137K 0.14% 96
2013
Q2 		$448K Buy
+16,870
New +$466K 0.11% 91

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Tufton Capital Management's PFE Position: Q3 2025 in Review

Tufton Capital Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,323 shares — an estimated $225K sold.

Tufton Capital Management first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $645K in Q1 2014. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Tufton Capital Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Tufton Capital Management sold 9,323 Pfizer shares in Q3 2025, an estimated $225K.
  • Tufton Capital Management first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
  • Tufton Capital Management's Pfizer position peaked at $645K in Q1 2014.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Tufton Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.